Mobile-health Network Solutions (MNDR) Registration filing summary

Company overview and business model

• Operates a telehealth platform (MaNaDr) offering teleconsultations, prescription delivery, and online/offline pharmacy sales across Singapore, Malaysia, Vietnam, and Indonesia.

• Revenue streams include telemedicine services (private/public sector), sale of prescription/non-prescription drugs, and healthcare products.

• Expansion through new subsidiaries and acquisitions in Southeast Asia during 2024–2025.

Financial performance and metrics

• FY2025 revenue: $7.65M (down from $13.97M in FY2024); net loss: $3.38M (improved from $15.60M loss in FY2024).

• Cash and cash equivalents as of June 30, 2025: $1.03M (down from $6.71M in 2024); negative operating cash flow of $4.36M in FY2025.

• Gross profit for FY2025: $1.28M; accumulated deficit: $28.14M.

• No customer or supplier concentration above 10% of sales or payables.

Use of proceeds and capital allocation

• Proceeds from IPO and equity agreements used for working capital, expansion, and technology development.

• Ongoing use of Standby Equity Subscription Agreement (SEPA) and At-the-Market (ATM) offerings to raise additional capital.